Kouichi Miura

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Antioxidants (Basel, Switzerland)

International journal of cancer

Life (Basel, Switzerland)

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Xian-Yang Qin, Yohei Shirakami, Masao Honda, Shiou-Hwei Yeh, Kazushi Numata, Ya-Yun Lai, Chiao-Ling Li, Feifei Wei, Yali Xu, Kenji Imai, Koji Takai, Makoto Chuma, Nagisa Komatsu, Yutaka Furutani, Luc Gailhouste, Hiroshi Aikata, Kazuaki Chayama, Masaru Enomoto, Ryosuke Tateishi, Kazunori Kawaguchi, Tatsuya Yamashita, Shuichi Kaneko, Katsuya Nagaoka, Motohiko Tanaka, Yutaka Sasaki, Yasuhito Tanaka, Hideo Baba, Kouichi Miura, Sae Ochi, Takahiro Masaki, Soichi Kojima, Tomokazu Matsuura, Masahito Shimizu, Pei-Jer Chen, Hisataka Moriwaki, Harukazu Suzuki
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence. International journal of cancer 155 (3) (2024)
Hiroshi Maeda, Kouichi Miura, Kenichi Aizawa, Oyunjargal Bat-Erdene, Miho Sashikawa-Kimura, Eri Noguchi, Masako Watanabe, Naoya Yamada, Hitoshi Osaka, Naoki Morimoto, Hironori Yamamoto
Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis. Antioxidants (Basel, Switzerland) 13 (7) (2024)
Hiroshi Maeda, Kouichi Miura, Kenichi Aizawa, Oyunjargal Bat-Erdene, Miho Sashikawa-Kimura, Eri Noguchi, Masako Watanabe, Naoya Yamada, Hitoshi Osaka, Naoki Morimoto, Hironori Yamamoto
Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis. Antioxidants (Basel, Switzerland) 13 (7) (2024)
Xian-Yang Qin, Yohei Shirakami, Masao Honda, Shiou-Hwei Yeh, Kazushi Numata, Ya-Yun Lai, Chiao-Ling Li, Feifei Wei, Yali Xu, Kenji Imai, Koji Takai, Makoto Chuma, Nagisa Komatsu, Yutaka Furutani, Luc Gailhouste, Hiroshi Aikata, Kazuaki Chayama, Masaru Enomoto, Ryosuke Tateishi, Kazunori Kawaguchi, Tatsuya Yamashita, Shuichi Kaneko, Katsuya Nagaoka, Motohiko Tanaka, Yutaka Sasaki, Yasuhito Tanaka, Hideo Baba, Kouichi Miura, Sae Ochi, Takahiro Masaki, Soichi Kojima, Tomokazu Matsuura, Masahito Shimizu, Pei-Jer Chen, Hisataka Moriwaki, Harukazu Suzuki
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence. International journal of cancer (2024)
Xian-Yang Qin, Yohei Shirakami, Masao Honda, Shiou-Hwei Yeh, Kazushi Numata, Ya-Yun Lai, Chiao-Ling Li, Feifei Wei, Yali Xu, Kenji Imai, Koji Takai, Makoto Chuma, Nagisa Komatsu, Yutaka Furutani, Luc Gailhouste, Hiroshi Aikata, Kazuaki Chayama, Masaru Enomoto, Ryosuke Tateishi, Kazunori Kawaguchi, Tatsuya Yamashita, Shuichi Kaneko, Katsuya Nagaoka, Motohiko Tanaka, Yutaka Sasaki, Yasuhito Tanaka, Hideo Baba, Kouichi Miura, Sae Ochi, Takahiro Masaki, Soichi Kojima, Tomokazu Matsuura, Masahito Shimizu, Pei-Jer Chen, Hisataka Moriwaki, Harukazu Suzuki
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence. International journal of cancer 155 (3) (2024)
Hiroshi Maeda, Kouichi Miura, Kenichi Aizawa, Oyunjargal Bat-Erdene, Miho Sashikawa-Kimura, Eri Noguchi, Masako Watanabe, Naoya Yamada, Hitoshi Osaka, Naoki Morimoto, Hironori Yamamoto
Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis. Antioxidants (Basel, Switzerland) 13 (7) (2024)
Satoshi Shinozaki, Toshiyuki Tahara, Kouichi Miura, Alan Kawarai Lefor, Hironori Yamamoto
Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study. Life (Basel, Switzerland) 13 (6) (2023)
Satoshi Shinozaki, Toshiyuki Tahara, Kouichi Miura, Alan Kawarai Lefor, Hironori Yamamoto
Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study. Life (Basel, Switzerland) 13 (6) (2023)
Hiroshi Maeda, Kouichi Miura, Naoki Morimoto, Shunji Watanabe, Mamiko Tsukui, Yoshinari Takaoka, Hiroaki Nomoto, Rie Goka, Naoto Sato, Kazue Morishima, Yasunaru Sakuma, Naohiro Sata, Noriyoshi Fukushima, Norio Isoda, Hironori Yamamoto
Conventional Therapies Do Not Prolong the Prognosis of Hepatocellular Carcinoma Patients with Extrahepatic Metastases under Receiving of Tyrosine Kinase Inhibitors. Cancers 14 (3) (2022)
Kouichi Miura, Naoshi Arai, Rie Goka, Naoki Morimoto, Shunji Watanabe, Norio Isoda, Hironori Yamamoto, Kazuhiko Kotani
Oxidized High-Density Lipoprotein Shows a Stepwise Increase as Fibrosis Progresses in Patients with Nonalcoholic Fatty Liver Disease. Antioxidants (Basel, Switzerland) 10 (2) (2021)
Kazuhiko Kotani, Jun Watanabe, Kouichi Miura, Alejandro Gugliucci
Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. Molecules (Basel, Switzerland) 26 (8) (2021)
Naoto Sato, Shunji Watanabe, Kouichi Miura, Naoki Morimoto, Yoshinari Takaoka, Hiroaki Nomoto, Norio Isoda, Shigeo Nagashima, Masaharu Takahashi, Hiroaki Okamoto, Hironori Yamamoto
Clinical and virologic features of hepatitis E virus infection at a university hospital in Japan between 2000 and 2019. Journal of medical virology (2020)
Kouichi Miura, Hirohide Ohnishi, Naoki Morimoto, Shinichiro Minami, Mitsuaki Ishioka, Shunji Watanabe, Mamiko Tsukui, Yoshinari Takaoka, Hiroaki Nomoto, Norio Isoda, Hironori Yamamoto
Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet. Cancer science 110 (2) (2019)

Kouichi Miura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kouichi Miura